Patients with severe aortic stenosis had comparable rates of death or disabling stroke, but the lead investigator cautions ...

Patients with severe aortic stenosis at low surgical risk who underwent supra-annular, self-expanding Evolut transcatheter ...

Medtronic, Abbott and Boston Scientific provided updates on their devices used in heart valve disease treatment at the event.

Pitted against more established balloon-expandable Sapien 3 valves in TAVR for severe aortic stenosis, the Myval devices ...

Researchers found that at five years, patients with severe aortic stenosis who were treated with either TAVR or surgery had comparable rates of all-cause mortality or disabling stroke.

The neobank was blasted for "violations and shortcomings in the monitoring of business relationships and [transactions]" by ...

Bearish flow noted in Medtronic (MDT) with 25,355 puts trading, or 7x expected. Most active are Jun-25 100 calls and Jan-26 85 puts, with total ...

BACKGROUND: Real-world low-risk transcatheter aortic valve replacement (TAVR) outcomes in the United States have not been assessed comprehensively versus pivotal trials, which is a key component of ...

Nokia processa Acer, ASUS e Hisense por suposta quebra de patentes Último post por Gustavo_001 (2 respostas) 0 min atrás em Outros Apple iPhone 16e: nova geração da Maçã por menos de R$ 4. ...